المؤلفون: Tomaszewska A., Jagasia M., Beohou E., van der Werf S., Blaise D., Kanfer E., Milpied N., Remenyi P., Ciceri F., Bourhis J. H., Chevallier P., Solano C., Socie G., Bruno B., Rambaldi A., Castagna L., Kroger N., Corradini P., Afanasyev B., Ladetto M., Niederwieser D., Scheid C., Sengeloev H., Kroschinsky F., Yakoub-Agha I., Schoemans H., Koenecke C., Penack O., Peric Z., Greinix H., Duarte R. F., Basak G. W.

المساهمون: Tomaszewska A., Jagasia M., Beohou E., van der Werf S., Blaise D., Kanfer E., Milpied N., Remenyi P., Ciceri F., Bourhis J.H., Chevallier P., Solano C., Socie G., Bruno B., Rambaldi A., Castagna L., Kroger N., Corradini P., Afanasyev B., Ladetto M., Niederwieser D., Scheid C., Sengeloev H., Kroschinsky F., Yakoub-Agha I., Schoemans H., Koenecke C., Penack O., Peric Z., Greinix H., Duarte R.F., Basak G.W.

مصطلحات موضوعية: B-cell malignancy, conditioning, graft-versus-host disease, non-relapse mortality after hematopoietic cell transplantation, rituximab, transplantation

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33603743; info:eu-repo/semantics/altIdentifier/wos/WOS:000618222400001; volume:11; firstpage:613954; lastpage:613962; numberofpages:9; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/2318/1874809Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100874273

الإتاحة: https://doi.org/10.3389/fimmu.2020.613954Test
http://hdl.handle.net/2318/1874809Test

المؤلفون: Grzegorz W. Basak, Boris V. Afanasyev, Péter Reményi, Noel Milpied, Paolo Corradini, Madan Jagasia, Olaf Penack, Henrik Sengeloev, Frank Kroschinsky, Zinaida Peric, Ibrahim Yakoub-Agha, Rafael F. Duarte, Dietger Niederwieser, Edward Kanfer, Steffie van der Werf, Fabio Ciceri, Alessandro Rambaldi, Didier Blaise, Patrice Chevallier, Carlos Solano, Hildegard Greinix, Eric Beohou, Luca Castagna, Nicolaus Kröger, Hélène Schoemans, Agnieszka Tomaszewska, Christian Koenecke, Jean Bourhis, Benedetto Bruno, Christof Scheid, Marco Ladetto, Gérard Socié

المساهمون: Tomaszewska, A., Jagasia, M., Beohou, E., van der Werf, S., Blaise, D., Kanfer, E., Milpied, N., Remenyi, P., Ciceri, F., Bourhis, J. H., Chevallier, P., Solano, C., Socie, G., Bruno, B., Rambaldi, A., Castagna, L., Kroger, N., Corradini, P., Afanasyev, B., Ladetto, M., Niederwieser, D., Scheid, C., Sengeloev, H., Kroschinsky, F., Yakoub-Agha, I., Schoemans, H., Koenecke, C., Penack, O., Peric, Z., Greinix, H., Duarte, R. F., Basak, G. W.

المصدر: Frontiers in Immunology
Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954Test
Frontiers in Immunology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

مصطلحات موضوعية: Oncology, Male, B-cell malignancy, Transplantation Conditioning, Graft vs Host Disease / etiology, Graft vs Host Disease, Disease, Rituximab / therapeutic use, Single Center, Transplantation Conditioning / methods, rituximab, conditioning, hemic and lymphatic diseases, Neoplasms, graft-versus-host disease, Immunology and Allergy, transplantation, B-cell malignancy, conditioning, rituximab, non-relapse mortality after hematopoietic cell transplantation, graft-versus-host disease, Registries, Young adult, Neoplasms / drug therapy, Original Research, B-Lymphocytes, Incidence (epidemiology), Hematopoietic Stem Cell Transplantation, Middle Aged, Rituximab, Female, Life Sciences & Biomedicine, medicine.drug, lcsh:Immunologic diseases. Allergy, Adult, medicine.medical_specialty, Lymphoma, B-Cell, Immunology, non-relapse mortality after hematopoietic cell transplantation, transplantation, Disease-Free Survival, Young Adult, Hematopoietic Stem Cell Transplantation / methods, Median follow-up, Internal medicine, medicine, Leukemia, B-Cell, Humans, ddc:610, Aged, Science & Technology, business.industry, Leukemia, B-Cell / drug therapy, medicine.disease, Transplantation, Graft-versus-host disease, B-Lymphocytes / drug effects, business, lcsh:RC581-607, Lymphoma, B-Cell / drug therapy

وصف الملف: application/pdf; Electronic-eCollection

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4d09c87c618906776d7cfa22d15fc6Test
http://europepmc.org/articles/PMC7884746Test